ID: ALA4104169

Max Phase: Preclinical

Molecular Formula: C16H23IN6O8S

Molecular Weight: 586.37

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)C[C@H](O)C(=O)NS(=O)(=O)OC[C@H]1O[C@@H](n2cnc3c(N)nc(I)nc32)[C@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C16H23IN6O8S/c1-6(2)3-7(24)14(27)22-32(28,29)30-4-8-10(25)11(26)15(31-8)23-5-19-9-12(18)20-16(17)21-13(9)23/h5-8,10-11,15,24-26H,3-4H2,1-2H3,(H,22,27)(H2,18,20,21)/t7-,8+,10+,11+,15+/m0/s1

Standard InChI Key:  WHBKHJPUBVIUDX-JVEUSOJLSA-N

Associated Targets(Human)

Leucyl-tRNA synthetase 173 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

mTORC1 330 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A549 127892 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HCT-116 91556 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

K562 73714 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MDA-MB-231 73002 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

SK-HEP1 1155 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

SNU-638 372 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MRC5 9203 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 586.37Molecular Weight (Monoisotopic): 586.0343AlogP: -1.58#Rotatable Bonds: 8
Polar Surface Area: 212.01Molecular Species: ACIDHBA: 13HBD: 5
#RO5 Violations: 2HBA (Lipinski): 14HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: 2.71CX Basic pKa: 2.13CX LogP: -1.08CX LogD: -1.51
Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.18Np Likeness Score: 0.81

References

1. Yoon S, Kim JH, Koh Y, Tran PT, Ann J, Yoon I, Jang J, Kim WK, Lee S, Lee J, Kim S, Lee J..  (2017)  Discovery of simplified leucyladenylate sulfamates as novel leucyl-tRNA synthetase (LRS)-targeted mammalian target of rapamycin complex 1 (mTORC1) inhibitors.,  25  (15): [PMID:28625715] [10.1016/j.bmc.2017.06.002]
2. Yoon S, Kim SE, Kim JH, Yoon I, Tran PT, Ann J, Kim C, Byun WS, Lee S, Kim S, Lee J, Lee J..  (2019)  Structure-activity relationship of leucyladenylate sulfamate analogues as leucyl-tRNA synthetase (LRS)-targeting inhibitors of Mammalian target of rapamycin complex 1 (mTORC1).,  27  (6): [PMID:30755350] [10.1016/j.bmc.2019.01.037]
3. Yoon S,Kim JH,Kim SE,Kim C,Tran PT,Ann J,Koh Y,Jang J,Kim S,Moon HS,Kim WK,Lee S,Lee J,Kim S,Lee J.  (2016)  Discovery of Leucyladenylate Sulfamates as Novel Leucyl-tRNA Synthetase (LRS)-Targeted Mammalian Target of Rapamycin Complex 1 (mTORC1) Inhibitors.,  59  (22): [PMID:27933890] [10.1021/acs.jmedchem.6b01190]

Source